Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Nystatin (Fungicidin): Polyene Antifungal Agent for Candi...

    2026-02-01

    Nystatin (Fungicidin): Polyene Antifungal Agent for Candida Research

    Executive Summary: Nystatin (Fungicidin) is a polyene antifungal antibiotic that binds ergosterol in fungal cell membranes, causing pore formation and cell death (APExBIO). Its minimal inhibitory concentration (MIC90) against Candida albicans is approximately 4 mg/L in standardized in vitro conditions (DOI). Liposomal Nystatin provides protective effects in Aspergillus infection models at doses as low as 2 mg/kg/day (DOI). The compound is soluble in DMSO at ≥30.45 mg/mL but insoluble in both ethanol and water (APExBIO). Inhibitor analysis demonstrates Nystatin does not block clathrin-mediated viral entry in aquatic reovirus models (DOI).

    Biological Rationale

    Nystatin (Fungicidin) is a polyene antifungal antibiotic used to study mechanisms of fungal cell death and antifungal resistance. It is effective against a spectrum of Candida species, including C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei (APExBIO). The compound is a reference standard for evaluating antifungal susceptibility and fungal adhesion to host epithelial cells. It also plays a critical role in preclinical models of invasive fungal infections, such as those caused by Aspergillus spp. (DOI).

    Mechanism of Action of Nystatin (Fungicidin)

    Nystatin binds specifically to ergosterol, a sterol unique to fungal cell membranes (see mechanistic specificity). This binding disrupts membrane integrity by forming transmembrane pores, leading to leakage of cellular constituents and cell death. The mechanism is selective, as ergosterol is absent in mammalian cell membranes, minimizing off-target cytotoxicity. Nystatin’s fungicidal effect is concentration-dependent and correlates directly with ergosterol content in the target organism (further mechanistic insight).

    Evidence & Benchmarks

    • Nystatin exhibits MIC90 of approximately 4 mg/L for C. albicans under standardized in vitro conditions (DOI:10.1128/AAC.00668-07).
    • Effective MIC values for non-albicans Candida species range from 0.39 to 3.12 μg/mL (DOI:10.1128/AAC.00668-07).
    • Nystatin reduces adhesion of Candida species to human buccal epithelial cells, although C. albicans adhesion is less affected than non-albicans species (see full adhesion analysis).
    • Liposomal Nystatin (2 mg/kg/day) confers protection against invasive Aspergillus infection in neutropenic murine models (DOI:10.1128/AAC.49.6.2382-2385.2005).
    • Nystatin does not inhibit clathrin-mediated viral entry in genotype III grass carp reovirus models (DOI:10.1186/s12985-018-0993-8).
    • The molecular weight of Nystatin is 926.09 Da, and the chemical formula is C47H75NO17 (APExBIO).
    • Nystatin is soluble in DMSO at ≥30.45 mg/mL, but insoluble in ethanol and water (APExBIO).

    Applications, Limits & Misconceptions

    Nystatin (Fungicidin) is primarily used in research settings to study antifungal activity, fungal adhesion, and antifungal resistance. It is a reference agent for evaluating new antifungal compounds and for validating infection models in Candida and Aspergillus research. Its action is limited to fungi containing ergosterol; it is ineffective against bacteria, viruses, and fungi that lack ergosterol. Comparative studies with other antifungals, such as amphotericin B and azoles, have established Nystatin’s unique mechanistic profile (see validated efficacy discussion—this article details specific benchmarks and expands on translational workflow integration beyond prior summaries).

    Common Pitfalls or Misconceptions

    • Nystatin is not effective against bacteria or viruses, as its mechanism requires ergosterol in the target membrane (DOI).
    • It does not inhibit clathrin-mediated endocytosis or serve as a general viral entry blocker (DOI).
    • Nystatin is inactive against fungi lacking ergosterol in their cell membranes.
    • Solutions are not stable for long-term storage and should be used promptly after preparation (APExBIO).
    • Oral and topical applications in clinical settings do not predict research efficacy in systemic or preclinical models.

    Workflow Integration & Parameters

    For laboratory use, Nystatin is supplied as a solid and can be reconstituted in DMSO at concentrations ≥30.45 mg/mL. The recommended storage temperature is -20°C. Stock solutions may be prepared by gentle warming and ultrasonic shaking to enhance solubility. Prepared solutions should be stored below -20°C and used within several months. The B1993 kit from APExBIO ensures lot-to-lot consistency for research applications (Nystatin (Fungicidin)).

    Researchers should avoid using ethanol or water as solvents due to insolubility. Nystatin is suitable for antifungal susceptibility testing, fungal adhesion assays, and in vivo infection models. For advanced mechanistic guidance, see this review, which discusses integration into translational research—this current article provides updated benchmarks and recent inhibitor analysis clarifications.

    Conclusion & Outlook

    Nystatin (Fungicidin) remains an essential tool for antifungal research, particularly in studies of Candida and Aspergillus species. Its well-characterized mechanism, reproducible efficacy, and robust solubility profile in DMSO make it suitable for diverse experimental workflows. Future research may focus on resistance trends in non-albicans Candida and on optimizing liposomal formulations for preclinical applications. For product specifications and detailed integration protocols, consult the APExBIO Nystatin (Fungicidin) B1993 page.